This Week in PLOS

Italian and American researchers, reporting in PLOS Pathogens, provide insights on a microRNA that appears to dissuade the immune system from performing autophagy in human dendritic cells infected with Mycobacterium tuberculosis. With array- and quantitative PCR-based analyses, the team followed miRNA expression at three, eight, and 24 hours after M. tuberculosis infection in dendritic cells, identifying dozens of differentially expressed miRNAs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.